Possible sepsis treatment needs additional evidence

Paul Marik, MD, an intensive care surgeon at the Eastern Virginia Medical School in Norfolk, claims he has been able to treat sepsis, the leading cause of death for patients in the hospital, in 150 patients with only one fatality.

Marik's proposed treatment involves an intravenous mix of corticosteroids, vitamins B and C, paired with precise management of fluids. While he says “extraordinary evidence” backs his treatment, others are calling for more research.

"Nothing has worked despite all the great ideas people have had, often ballyhooed with observational data like this, claiming that it's a big effect," said Robert Califf, MD, who recently returned to Duke University after running the U.S. Food and Drug Administration.

Read the full story by clicking the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.